Cronos Group Inc

In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

Aurora Cannabis is set to release its fiscal 2020 first-quarter earnings results on November 11. Let’s see what analysts expect for its upcoming quarter.

Aurora Cannabis (ACB) stock is currently down 29.23% on the NYSE on a YTD (year-to-date) basis. The company has lost 14.81% of its value since October 1.

The Day reported that New York, New Jersey, Connecticut, and Pennsylvania’s governors met and agreed on basic guidelines for legalizing marijuana.

Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.

Mexico is ready with a revised proposal to legalize marijuana this year. The Supreme Court gave lawmakers until April 30 to submit the new proposal.

Recreational cannabis is close to being legalized in Canada, and producers are running at full bore to capture a piece of the market.

This week is important for the cannabis sector, as Canopy Growth and Aurora Cannabis are both set to report their earnings results on November 14.

Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group.

AGLC will allow retail stores in Alberta to sell marijuana vape products. Consumers will likely be able to purchase cannabis vape products in the next two weeks.

Apple removed 181 vaping-related apps due to the vape crisis in the US. Canopy Growth is not happy with Apple’s move. Let’s see why.

Marijuana laws are pretty strict in Wisconsin. Although cannabis is spreading its roots across US states, it’s still illegal at the federal level. President Trump and his administration want states to decide. Florida, New York, and Minnesota are all gearing up to legalize adult-use cannabis. Now, Wisconsin is pushing to legalize medical marijuana. Let’s see […]

According to a Reuters report on December 3, Brazil is ready to approve medical cannabis products. Currently, cannabis is illegal in Brazil.

With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization.

Vaping has become very popular. However, investigations by the FTC and FDA sparked more concerns. Juul’s vaping devices could cause seizures.

The Canadian Press reported that Canopy Growth is partnering with rapper Drake to launch a new cannabis venture, the More Life Growth Company.

Canopy Growth (NYSE:CGC) lost 25.4% in 2019. The company reported weak sales and higher-than-expected operating losses in the last two quarters.

Canopy Growth (CGC) has seen dizzying ups and gloomy downs in 2019. The stock jumped up by 79.91% from $28.92 on January 2 to $52.03 on April 29.

Canopy Growth has struggled this year. Despite all their strategies, cannabis companies have failed to hit revenue and profitability targets this year.

It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.

Amid a subdued cannabis sector, Aurora Cannabis (ACB) stock has taken a serious hit and is down 36.4% this month. Is this the right time to invest?

New Hampshire legalized medical cannabis, but using cannabis for recreational purposes is still prohibited. The state legalized medical marijuana in 2013.

The FDA has issued warning letters to 15 companies involved in illegal sales of non-psychoactive CBD products. What’s the legal market’s potential?

As the cannabis space has increasingly become crowded, companies such as Cronos Group would greatly benefit from a company such as Altria.

Recreational cannabis isn’t legal in Maryland, but the state has been trying to launch edibles as part of its medical marijuana program.

So far, cannabis stocks have rebounded in 2020, which investors expected. The marijuana industry struggled in 2019. Overall, the rebound will take time.

For the second quarter of fiscal 2020, analysts expect Hexo’s revenue to grow 25.5% YoY (year-over-year) to 16.8 million Canadian dollars.

In October, Canada completed the second phase of recreational cannabis legalization. This was expected to help drive sales. But that hasn’t been the case.

Cronos Group and Aphria are Jim Cramer’s top picks in the cannabis sector. Aphria’s upbeat earnings results restored investors’ faith in the sector.

Aurora Cannabis saw less of an impact from COVID-19 in the third quarter. Cannabis is an essential item amid the pandemic.

Charlotte’s Web Holdings (NYSEARCA:CWEB) is one of the main players in the CBD business. The company plans to keep expanding in 2020.

Earlier this week, Rahul Sarugaser of Raymond James upgraded Cronos Group (NASDAQ:CRON) from “market perform” to “outperform.”

So far this year, Philip Morris International (NYSE:PM) and Altria Group (NYSE:MO) have underperformed the broader equity markets.

Aurora Cannabis (NYSE:ACB) reported its third-quarter results on May 14. The earnings report was a surprise for most analysts and investors.

Constellation Brands (NYSE:STZ) expressed its confidence in Canopy Growth (NYSE:CGC)(TSE:WEED) by increasing its stake in the company.

Marijuana is gaining a lot of attention amid the coronavirus pandemic. Many people think that Joe Biden should support marijuana legalization.

Medical marijuana legalization won’t happen in Idaho in 2020 due to the coronavirus pandemic. The ICC couldn’t gather the required signatures.

New York lawmakers decided to delay marijuana legalization due to the COVID-19 pandemic. As a result, New York won’t see marijuana legalization in 2020.

MedMen stock fell by 12.0% on March 30 after the company released some corporate updates. MedMen has been struggling with a cash crunch.

On Tuesday, Canopy Growth (NYSE:CGC)(TSE:WEED) announced that it will temporarily close all of its company-owned Tokyo Smoke and Tweed retail stores.

Hexo (TSE:HEXO) has been struggling for a while now. The string of bad news started in October 2019 when CFO Michael Monahan resigned.

Aurora Cannabis (NYSE:ACB) stock has fallen below $1 on the NYSE, which puts it at the risk of being delisted from the exchange.

The marijuana legalization process in US states is speeding up in 2020. Many new states are coming up with their own proposals to legalize marijuana.

Canopy Growth will report its earnings for the third quarter of fiscal 2020 before the market opens on Friday. Analysts expect the revenue to rise.

Tulsi Gabbard has been a big supporter of marijuana legalization. Recently, she spoke about how she wants all illicit drugs to be legal and not just marijuana.

Most US states are looking forward to cannabis legalization in 2020. Recently, Governor Andrew Cuomo promised to legalize cannabis in New York in 2020.

On January 10, HEXO was trading at 1.74 Canadian dollars, a fall of 63.1% since the beginning of 2019 and a discount of 84.6% to its 52-week high.

Cronos Group (CRON) stock rose 33% with a heavy volume in after-hours trading on Wednesday. Marijuana stocks are on a rollercoaster ride.

Cannabis demand is rising, but there seems to be a gap between cannabis demand and supply in Canada. Let’s take a closer look at the imbalance.

Aphria impressed analysts and cannabis investors in 2019. While the cannabis sector’s struggles pulled down Aphria stock, the company did well overall.